Sacroilitis: Symptoms and Treatment
Typical Symptoms
Sacroiliitis presents primarily as lower back pain that can radiate down the legs, accounting for up to 25% of all lower back pain cases 1. The pain arises from inflammation of one or both sacroiliac joints and can be debilitating, with patients reporting some of the lowest quality of life scores among chronic diseases 2.
Key clinical features to identify:
- Pain localization: Lower back pain with potential radiation to buttocks, hips, and posterior thighs
- Pain patterns: Often worse with prolonged standing, climbing stairs, or transitioning from sitting to standing
- Inflammatory characteristics: Morning stiffness, improvement with activity (in inflammatory causes)
- Diagnostic challenge: The intricate ligamentous structure and nerve innervation make diagnosis difficult 1
Diagnostic confirmation requires fluoroscopy-guided joint block with local anesthetic—pain reduction following injection is the gold standard for diagnosis 1.
Treatment Algorithm
First-Line: NSAIDs
NSAIDs are strongly recommended as initial pharmacological management for active sacroiliitis 3.
- Continuous NSAID therapy is conditionally recommended over on-demand treatment in active disease 3
- No particular NSAID is preferred over another 3
- Important caveat: NSAIDs can mask active inflammation on MRI—one-fifth of patients show complete resolution of inflammatory lesions on imaging while taking NSAIDs 4. Consider a 1-2 week NSAID washout before diagnostic MRI if clinically feasible.
- For stable disease, switch to on-demand NSAIDs 3, 5
Second-Line: Local Glucocorticoid Injections
In isolated active sacroiliitis despite NSAID treatment, local glucocorticoid administration is conditionally recommended 3.
- Ultrasound or fluoroscopy-guided injections are safe and effective 6
- Strongly recommended against long-term systemic glucocorticoids 3, 5
- Local injections are particularly useful in pregnancy/post-partum when systemic options are limited 6
Third-Line: Biologic DMARDs or JAK Inhibitors
For active sacroiliitis with inadequate response to NSAIDs, biologic DMARDs (TNF inhibitors or IL-17 inhibitors) are strongly recommended 3.
Treatment hierarchy:
- First choice: TNF inhibitors or IL-17 inhibitors (secukinumab, ixekizumab) 3, 5
- When biologics are contraindicated or unavailable: JAK inhibitors are strongly recommended 3
- Biosimilars are strongly recommended as equivalent therapeutic options 3
Switching Strategy for Treatment Failure
- Primary failure (never responded): Switch to a biologic with different mechanism of action (e.g., TNF inhibitor to IL-17 inhibitor or vice versa) or JAK inhibitor 3
- Secondary failure (lost response): Can cycle or switch between any of the three mechanisms (TNF inhibition, IL-17 inhibition, JAK inhibition) 3
What NOT to Use
Conventional synthetic DMARDs (sulfasalazine, methotrexate, leflunomide) are strongly recommended against for purely axial involvement 3, 5. These agents lack verified efficacy for axial disease 7.
Adjunctive Therapy
Physical therapy is strongly recommended over no physical therapy 5.
- Active supervised exercise is preferred over passive modalities (massage, ultrasound, heat) 5
- Land-based therapy is conditionally preferred over aquatic therapy 5
Special Considerations
Infectious Sacroiliitis
If pyogenic sacroiliitis is suspected (most common cause of acute sacroiliitis 8):
- Antibiotics are the treatment of choice 7
- Requires detailed imaging (CT or MRI) to characterize extent and diagnose complications 8
- Brucellosis, reactive arthritis, and crystalline-induced sacroiliitis can mimic pyogenic infection 8
Refractory Cases
For cases failing conservative and biologic therapy, interventional options include 1, 9, 2:
- Radiofrequency ablation
- Prolotherapy
- Minimally invasive SI joint fusion surgery (reserved for severe refractory cases)
Maintenance Therapy
Once remission is achieved with biologics, discontinue NSAIDs and/or csDMARDs—continue biologic monotherapy 3. Avoid routine biologic dose tapering or discontinuation 5.